Abstract:Background: Doxorubicin (DOX) is an effective antineoplastic agent of the anthracycline group. However, as with most anticancer drugs, they cause some toxic effects, including major cardiotoxicity. Oxidative stress, inflammation and apoptosis contribute to the pathological basis of doxorubicin (DOX)-induced cardiotoxicity. Indole-3-carbinol is a cruciferous-derived phytochemical, with potential anti-inflammatory and antioxidant effects. Purpose: Our present study aimed to investigate the protective effects of I3C against DOX- induced cardiotoxicity in mice by Targeting Inflammation, Oxidative Stress, and Apoptosis. Methods: BALB/c mice were subjected to DOX (4 mg/kg/day, i.p.) once weekly on days 0, 7, 14, 21 (for 21 days) to generate DOX- induced cardiotoxicity. Indole-3-carbinol was administered daily orally in the diet at two dose levels; 1000 ppm and 2000 ppm for 7 days before and 42 days after first injection of DOX. Serum creatine kinase (CK-MB), lactate dehydrogenase (LDH) and troponin I (cTn-I) levels activities, which are cardiac function markers were determined. Also, the levels of malondialdehyde (MDA) was assessed and enzyme activities of superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GR) and glutathione peroxidase (GPx) were assessed in the heart tissues to determine the protective effect of Indole-3-carbinol against oxidative stress. To determine the anti-inflammatory effect, the levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) were assessed in the heart tissues. Parts of the heart were subjected to histopathological and immunohistochemical examinations. Results: Indole-3-carbinol in a dose‐dependent manner was found to have the ability to mitigate the harmful effects of DOX on myocardial muscles with significant decrease in serum levels of CK-MB, LDH and cTn-I. In addition, Indole-3-carbinol significantly inhibited DOX-induced cardiac oxidative stress as seen in the reduced level of MDA and increased SOD, CAT, GR and GPx cardiac tissue levels; Indole-3-carbinol significantly reduced inflammatory mediators TNF-α and IL-6 levels and inhibited cardiac apoptosis by modulating Caspase 3 cardiac tissue levels. Moreover, Indole-3-carbinol, in a dose‐dependent manner, had the ability to combat the histopathological and immunohistochemical changes induced by doxorubicin in cardiomyocytes. Conclusion: These results demonstrate that administration of I3C in a dose dependent manner prevents heart injury induced by DOX via its antioxidant, anti-inflammatory, and antiapoptotic activities.

Beneficial effects of carbon monoxide-releasing molecule-2 (CORM-2) on acute doxorubicin cardiotoxicity in mice: role of oxidative stress and apoptosis

Early Transcriptional Changes in Cardiac Mitochondria During Chronic Doxorubicin Exposure and Mitigation by Dexrazoxane in Mice.

Small-molecule mediated MuRF1 inhibition protects from doxorubicin-induced cardiac atrophy and contractile dysfunction

Carbon monoxide-releasing molecule-2 ameliorates postresuscitation myocardial dysfunction in rat via mitochondrial-mediated apoptosis pathway and the regulation of mitochondrial dynamics

Beneficial Effects of Oral Carbon Monoxide on Doxorubicin-Induced Cardiotoxicity

Primary Protection of Diosmin Against Doxorubicin Cardiotoxicity via Inhibiting Oxido-Inflammatory Stress and Apoptosis in Rats

Effects of Carbon Monoxide Releasing Molecule-2 on Post-Resuscitation Myocardial Dysfunction

Cardamonin protects against doxorubicin-induced cardiotoxicity in mice by restraining oxidative stress and inflammation associated with Nrf2 signaling.

Targeting Inflammation, Oxidative Stress, and Apoptosis by Indole-3-Carbinol to Ameliorate Doxorubicin- Induced Cardiotoxicity in Mice

Oxymatrine Ameliorates Doxorubicin-Induced Cardiotoxicity in Rats

NMCP‐2 Polysaccharide Purified from Morchella Conica Effectively Prevents Doxorubicin‐induced Cardiotoxicity by Decreasing Cardiomyocyte Apoptosis and Myocardial Oxidative Stress

Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats

The impact of PPAR-γ/Nrf-2/HO-1, NF-κB/IL-6/ Keap-1, and Bcl-2/caspase-3/ATG-5 pathways in mitigation of DOX-induced cardiotoxicity in an animal model: The potential cardioprotective role of oxyresveratrol and/or dapagliflozin

Nerolidol Attenuates Oxidative Stress, Inflammation, and Apoptosis by Modulating Nrf2/MAPK Signaling Pathways in Doxorubicin-Induced Acute Cardiotoxicity in Rats

RRM2 Alleviates Doxorubicin-Induced Cardiotoxicity through the AKT/mTOR Signaling Pathway

Carbon Monoxide Releasing Molecule-2 Attenuated Ischemia/Reperfusion-Induced Apoptosis in Cardiomyocytes Via A Mitochondrial Pathway

Cariporide Attenuates Doxorubicin-Induced Cardiotoxicity in Rats by Inhibiting Oxidative Stress, Inflammation and Apoptosis Partly Through Regulation of Akt/GSK-3β and Sirt1 Signaling Pathway

Carbon monoxide-releasing molecules attenuate postresuscitation myocardial injury and protect cardiac mitochondrial function by reducing the production of mitochondrial reactive oxygen species in a rat model of cardiac arrest.

Curcumin Attenuates Doxorubicin-Induced Cardiac Oxidative Stress and Increases Survival in Mice

Dimethyl Fumarate Ameliorates Doxorubicin-Induced Cardiotoxicity by Activating the Nrf2 Pathway

Metabolic remodeling associated with subchronic doxorubicin cardiomyopathy